- Home
- WINT vs AGMH Comparison
WINT vs AGMH Comparison
Compare WINT & AGMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WINT
- AGMH
- Stock Information
- Founded
- WINT 1992
- AGMH 2015
- Country
- WINT United States
- AGMH Hong Kong
- Employees
- WINT N/A
- AGMH N/A
- Industry
- WINT Biotechnology: Biological Products (No Diagnostic Substances)
- AGMH EDP Services
- Sector
- WINT Health Care
- AGMH Technology
- Exchange
- WINT Nasdaq
- AGMH Nasdaq
- Market Cap
- WINT 3.6M
- AGMH 3.5M
- IPO Year
- WINT 1995
- AGMH 2018
- Fundamental
- Price
- WINT $0.83
- AGMH $0.07
- Analyst Decision
- WINT Hold
- AGMH
- Analyst Count
- WINT 1
- AGMH 0
- Target Price
- WINT $350.00
- AGMH N/A
- AVG Volume (30 Days)
- WINT 224.2K
- AGMH 211.8M
- Earning Date
- WINT 05-16-2025
- AGMH 06-18-2025
- Dividend Yield
- WINT N/A
- AGMH N/A
- EPS Growth
- WINT N/A
- AGMH N/A
- EPS
- WINT N/A
- AGMH 0.13
- Revenue
- WINT N/A
- AGMH $32,044,575.00
- Revenue This Year
- WINT N/A
- AGMH N/A
- Revenue Next Year
- WINT N/A
- AGMH N/A
- P/E Ratio
- WINT N/A
- AGMH $0.43
- Revenue Growth
- WINT N/A
- AGMH N/A
- 52 Week Low
- WINT $1.01
- AGMH $0.02
- 52 Week High
- WINT $737.50
- AGMH $2.19
- Technical
- Relative Strength Index (RSI)
- WINT 29.36
- AGMH 43.46
- Support Level
- WINT $0.81
- AGMH $0.06
- Resistance Level
- WINT $0.95
- AGMH $0.10
- Average True Range (ATR)
- WINT 0.09
- AGMH 0.02
- MACD
- WINT 0.04
- AGMH 0.00
- Stochastic Oscillator
- WINT 6.14
- AGMH 7.53
About WINT Windtree Therapeutics Inc.
Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.
About AGMH AGM Group Holdings Inc.
AGM Group Holdings Inc is an investment holding company. The company focuses on blockchain-oriented ASIC chip design; high-end crypto miner production and fintech technology software service. It generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.